Sub-licensing Agreement for the Oral Spleen Tyrosine Kinase Inhibitor TAVALISSE® with Tai Tien Pharmaceuticals in Taiwan
This document is hosted externally.
Unless the owner has removed it from the web, you can access the full document via its original URL:
https://moneyworld.jp/discl-pdf/tdnet/2025010754734501GENERAL.pdfUnless the owner has removed it from the web, you can access the full document via its original URL:
See similar contracts (1)
Alternatively, you can try searching for similar contracts: